User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.

  • Open access
  • PDF
  • 720.42 K
Bibliographic reference Devos, Timothy ; Geukens, Tatjana ; Schauwvlieghe, Alexander ; Ariën, Kevin K ; Barbezange, Cyril ; et. al. A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial.. In: Trials, Vol. 21, no.1, p. 981 [1-15] (2020)
Permanent URL http://hdl.handle.net/2078.1/253877